Salute e Benessere

Theriva Biologics Selected as Finalist in International Competition for Merck…

Winner to be Presented at BIO-Europe 2024 in Stockholm, Sweden Manel Cascalló, PhD., General Director - EU Subsidiary, Theriva Biologics, will present an overview of VCN-01, currently being studied in a Phase 2b clinical trial in first-line metastatic pancreatic cancer in combination with standard-of-care chemotherapy. Dr Cascalló will highlight VCN-01's novel mechanisms of action and Theriva's internal capabilities to develop its manufacturing process in his presentation on Monday,...
Nasdaq GlobeNewswire
31/10/2024

Sabin Sends More Marburg Vaccines for Rwanda's Outbreak

Photo caption: Rwanda Minister of State for Health, Yvan Butera, was among those who received Sabin's investigational vaccine in the open-label clinical trial.WASHINGTON, Oct.31, 2024(GLOBE NEWSWIRE) -- In continued collaboration with Rwanda to address the Marburg virus outbreak, the Sabin Vaccine Institute has dispatched approximately 1,000 additional investigational vaccine doses for a randomized clinical trial arm within the ongoing open-label study. More than 1,500 frontline...
Nasdaq GlobeNewswire
31/10/2024

KFSHRC Leads Ethical Integration of AI in Healthcare

RIYADH, Saudi Arabia, Oct.31, 2024(GLOBE NEWSWIRE) -- Responsible integration has become imperative as Artificial Intelligence (AI) continue to reshape the medical landscape. King Faisal Specialist Hospital & Research Centre (KFSHRC) emphasizes patient safety, transparency, and accountability by integrating critical medical advancements within a framework of ethical responsibility.Since its launch in 2019, KFSHRC's Center for Healthcare Intelligence (CHI) has developed over 20...
Nasdaq GlobeNewswire
31/10/2024

GUERBET : Financial agenda for 2025

Financial agenda for 2025Villepinte, 31 October 2024:Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, is announcing its financial agenda for 2025. Publications calendar 2024 ANNUAL REVENUE February 06, 2025,after trading2024 ANNUAL RESULTS March 27, 2025, after trading2025 1 stQUARTER REVENUE April 24, 2025,after tradingANNUAL SHAREHOLDERS' MEETING May 23, 2025 2025 2 ndQUARTER...
Nasdaq GlobeNewswire
31/10/2024

Casino Group: Q3 2024 publication

THIRD-QUARTER 2024Restructuring plan now secured Hypermarkets and Supermarkets disposals completed on schedule 425 stores sold since September 2023, of which 135 in Q3 2024 and 18 on 1 October 2024The activity of all hypermarkets and supermarkets operated by the Group has now virtually ceased, with the remaining stores 1to be sold or closed by year-end Approval and roll-out of Employment Protection Plans Seven agreements signed with trade unions and validated by the...
Nasdaq GlobeNewswire
31/10/2024

Monica Lewinsky Visits Agnivesh Agarwal's Primeks Medical, Advocates Against…

The internationally recognized cyberbullying activist partners with Primeks Medical in Istanbul during National Cybersecurity Awareness Month, bringing attention to critical social issues and supporting Turkey's growing medical tourism sector. During her time in Istanbul, Lewinsky addressed students at a private high school, delivering a powerful talk on the dangers and long-term effects of cyberbullying. She highlighted the importance of empathy and encouraged students to speak out against...
Nasdaq GlobeNewswire
31/10/2024

Director/PDMR Shareholding

DXS INTERNATIONAL PLC(AQSE: DXSP)Notification of Director / PDMR DealingDXS INTERNATIONAL PLC The Board of DXS International plc (the “Company” or “DXSP), the AQSE Growth Market quoted clinical decision support developer and supplier of clinical decision support systems, has received notification that on 30 October 2024 Mr Bob Sutcliffe, the Chairman, purchased a total of 50,000 Ordinary Shares in the Company at a price of 1.0p per share. Further, today 31 October 2024, Mr Bob...
Nasdaq GlobeNewswire
31/10/2024

Advanced Visualization Market to Hit USD 6.55 Billion by 2029 with 11.7% CAGR |…

Browse in-depth TOC on "Advanced Visualization Market" Browse in-depth TOC on "Advanced Visualization Market" 455 - Tables 54 - Figures 386 - Pages Artificial Intelligence (AI) and Machine Learning (ML) are revolutionizing advanced visualization by enabling advanced data analysis, pattern recognition, and predictive modelling, which are crucial for early disease diagnosis to improve diagnostic efficiency & accuracy. Companies are investing in leveraging AI & ML…
PR Newswire
31/10/2024

Water Flosser Market Surges to USD 1,418.81 Million by 2030, Propelled by 5.3%…

Download PDF Brochure: https://www.verifiedmarketreports.com/download-sample/?rid=841408 Download PDF Brochure: https://www.verifiedmarketreports.com/download-sample/?rid=841408 Browse in-depth TOC on Water Flosser Market 202 - Pages 126 – Tables 37 – Figures Scope of The Report Global Water Flosser Market Overview Rising Awareness of Oral Health and Hygiene Consumers are increasingly aware of the importance of oral health, leading to a growing demand for...
PR Newswire
31/10/2024

Occupancy Sensor Market worth $5.20 billion in 2030 - Exclusive Report by…

Browse in-depth TOC on "Occupancy Sensor Market" 200 – Tables62 – Figures229 – Pages Browse in-depth TOC on "Occupancy Sensor Market"200 – Tables 62 – Figures 229 – Pages Occupancy Sensor Market Report Scope: The 180-360°segment is expected to grow fastest in forecast period. The 180-360°is expected to grow fastest during the forecast period due to its ability to provide full monitoring and detection capabilities in larger and more complex spaces. These sensors can cover...
PR Newswire
31/10/2024

Veterinary Vaccines Market is expected to generate a revenue of USD 27.5 Billion…

As the global veterinary vaccines market continues to witness robust growth, industry stakeholders need actionable insights to stay ahead. Our report provides an unparalleled view into the factors driving market expansion, such as rising zoonotic disease prevalence, heightened regulatory demands for vaccine quality and safety, and advances in biotechnology enabling more efficient and effective vaccine formulations. With data-driven forecasts, emerging trends, and competitive landscape analysis…
PR Newswire
31/10/2024

B.More Collaborator, Dr. Michael Bogenschutz, Awarded $15 Million NIDA Grant for…

Participants will receive manualized, non-directive clinical support and will be randomly assigned to receive a single administration of psilocybin 30 mg (high dose), psilocybin 20 mg (medium dose), or psilocybin 1 mg (low-dose control condition). Weekly urine drug screens and continuous self-report of opioid and other drug use will be collected for 24 weeks after psilocybin administration, along with measures probing OUD-related neuropsychopathology and functional outcomes. Participants will...
PR Newswire
31/10/2024

e-therapeutics Announces Business Updates and Interim Results

Ali Mortazavi, CEO, said: “We continue to make strong and rapid progress towards becoming a clinical-stage biotech company, as we advance our pipeline of novel GalOmic therapies, aiming to file our first IND submission in 2025. I am also excited about the ongoing evolution of HepNet. Our investment in AWS infrastructure demonstrates our commitment to integrating cutting-edge technologies across our platform. To further these efforts, we are thrilled to welcome Dr Lee Clewley as our...
Nasdaq GlobeNewswire
31/10/2024

TechBio Startup Cure51 Selects 10x Genomics Visium HD for New Drug Discovery…

Working alongside more than 50 oncologic centres, Cure51 intends to collect and analyze tumor tissues from over 1,000 exceptional cancer survivors across 40 countries in the next 18 months. By using Visium HD from 10x Genomics, Cure51 aims to uncover new insights into long-term cancer survival mechanisms and build the first proprietary multi-omics database of exceptional cancer survivors. Working alongside more than 50 oncologic centres, Cure51 intends to collect and analyze tumor tissues…
PR Newswire
31/10/2024

SKF completes acquisition of John Sample Group

JSG had approximately SEK 550 million of net sales in their latest fiscal year and 85 employees, with operations in Australia, New Zealand, Indonesia and Singapore. The company will be integrated into SKF's existing lubrication management business. JSG had approximatelySEK 550 millionof net sales in their latest fiscal year and 85 employees, with operations inAustralia,New Zealand,IndonesiaandSingapore. The company will be integrated into SKF's existing lubrication management...
PR Newswire
31/10/2024

Evaxion announces business update and third quarter 2024 financial results

/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, provides business update and announces third quarter 2024 financial results. Business highlights (since last quarterly update) Since the second quarter 2024 business update, we have continued to execute strongly on our strategy and plans with several major milestones achieved. Key highlights include: Significant expansion of the infectious disease vaccine...
Nasdaq GlobeNewswire
31/10/2024

BioNTech to Host Innovation Series R&D Day on November 14, 2024

MAINZ, Germany, October 31 , 2024 (GLOBE NEWSWIRE)-- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”), will host an edition of the Company's Innovation Series R&D Day at 10:30 a.m. Eastern Standard Time (16:30 p.m. CET) on Thursday, November 14, 2024 in New York City, U.S.On the day, BioNTech's leadership team will provide an overview of the Company's corporate strategy and clinical progress across its pipeline.Investors, analysts and the interested public are invited...
Nasdaq GlobeNewswire
31/10/2024

Loftware and Signant Health Announce Availability of Integrated Clinical…

The new integration supports automation in three key areas. Firstly, it allows clinical trial master data held in GxP Inventory to be transferred into the Loftware Cloud Clinical Trials platform, removing the risk of errors from manual entry processes. Secondly, print requests can be created and approved directly within the GxP Inventory application, thereby improving efficiency and usability. Finally, print status updates are then sent back from Loftware Cloud Clinical Trials to GxP Inventory…
PR Newswire
31/10/2024

PureHealth Posts Net Profit of AED 1.4 Billion and Revenues Increase of 56% for…

Hamad Al Hammadi ,Chairman of PureHealth,said : "As we progress along our defined growth trajectory, we remain dedicated to advancing the science of longevity in the pursuit of improving quality of life. The strategic acquisitions made this year have significantly strengthened PureHealth's global position as an integrated healthcare platform, granting access to a premium cross-sector ecosystem. Our performance metrics underscore our commitment to driving innovation, achieving...
PR Newswire
31/10/2024

Teva Statement on European Commission Decision; Company to Appeal

Teva Pharmaceuticals disagrees with the European Commission decision, which is based on legal theories that the company believes are extreme, untested, and factually unsupportedThe company intends to appeal the outcome and is fully prepared to mount its defense Teva has supported the MS community since 1996 and will not be distracted from providing access to this important standard-of-care treatment Teva works to the highest ethical standards with all our external experts and do...
Nasdaq GlobeNewswire
31/10/2024

Kling Biotherapeutics to Present Key Applications for its Primary B-Cell…

Poster two entitled 'Kling-Evolve as a tool for rapid response to emerging variants and pandemic preparedness: directed evolution of variant-specific antibody from immortalized B cells,' details the Kling-Evolve platform which enables the rapid ex vivo maturation of immortalized human B cells to identify neutralizing antibodies against escape variants. Kling-Evolve poses the potential for rapid development of countermeasures to combat and pre-emptively address evolving viruses amidst emerging…
PR Newswire
31/10/2024

Healthcare Holding Schweiz/Winterberg Acquire MVB Medizintechnik AG

Fabian Kroeher, President of the Board of Healthcare Holding Schweiz and Partner at Winterberg Advisory GmbH, stated, "We are excited to welcome MVB Medizintechnik AG into the Healthcare Holding family. This acquisition not only broadens our product offerings but also enhances our capability to deliver tailored solutions to our customers. The integration of MVB's specialized knowledge and innovative products will significantly contribute to our growth strategy." Fabian Kroeher…
PR Newswire
31/10/2024

Lecanemab data presented at CTAD on early initiation and long-term treatment…

Benefits of continued treatment with lecanemab for people with early Alzheimer's disease Benefits of continued treatment with lecanemab for people with early Alzheimer's disease Results from the open-label long-term extension study (OLE) following the core study of the lecanemab phase 3 Clarity AD study presented at AAIC in July, showed that the mean change from baseline in CDR-SB (global cognitive and functional scale) in the lecanemab treated group was -0.45 at 18 months compared to the...
PR Newswire
31/10/2024

NANOBIOTIX to Participate in Multiple Investor Conferences in November

~ Guggenheim's Inaugural Healthcare Innovation Conference, Nov 11-13 ~~ Stifel Healthcare Conference, Nov 18-19 ~~ Jefferies London Healthcare Conference, Nov 19-21 ~ PARIS and CAMBRIDGE, Mass., Oct.31, 2024(GLOBE NEWSWIRE) --NANOBIOTIX(Euronext: NANO –– NASDAQ: NBTX – the '' Company ''), a late-clinical stage biotechnology company pioneering nanoparticle-based approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today...
Nasdaq GlobeNewswire
31/10/2024
Altri  Comunicati